Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
08/2000
08/23/2000EP1029072A1 Method for identifying drug targets
08/23/2000EP1029058A1 Dna demethylase, therapeutic and diagnostic uses thereof
08/23/2000EP1029050A1 Tumor-specific antigens, methods for their production and their use for immunization and diagnosis
08/23/2000EP1029041A2 Hyperthermic inducible expression vectors for gene therapy and methods of use thereof
08/23/2000EP1028977A2 Bifidus stimulating peptides
08/23/2000EP1028975A1 Artemin, a novel neurotrophic factor
08/23/2000EP1028974A1 Secreted proteins and polynucleotides encoding them
08/23/2000EP1028964A1 Thienopyrimidine and thienopyridine derivatives useful as anticancer agents
08/23/2000EP1028945A1 Substituted pyridine compounds as anti-inflammatory agents
08/23/2000EP1028942A2 Dipeptide nitriles
08/23/2000EP1028758A1 Methods for treating prostate tumors using radioactive compositions
08/23/2000EP1028757A1 Radioactive embolizing compositions
08/23/2000EP1028751A1 Methods and compositions comprising glycoprotein glycoforms
08/23/2000EP1028745A1 Interferon immunotherapy
08/23/2000EP1028739A2 Use of protein h as cytostatic agent
08/23/2000EP1028729A2 Methods of modulating serine/threonine protein kinase function with 5-azaquinoxaline-based compounds
08/23/2000EP1028721A1 $i(N,N')-BIS(SULFONYL)HYDRAZINES USEFUL AS ANTINEOPLASTIC AGENTS
08/23/2000EP0844873A4 Carotenoid-nicotinamide-zinc compositions and methods of treatment using same
08/23/2000EP0821668B1 Derivatives of succinamide and their use as metalloproteinase inhibitor
08/23/2000EP0729473B1 Glucosamine disaccharides, method for their preparation, pharmaceutical composition comprising same, and their use
08/23/2000EP0723547B1 Boronated metalloporphyrins and diagnostic methods
08/23/2000EP0666844B1 Inhibitors of farnesyl-protein transferase
08/23/2000EP0658159B1 Arylidene and heteroarylidene oxindole derivatives as tyrosine kinase inhibitors
08/23/2000EP0640072B1 Derivatives of pyridine as hydroxylase and lyase inhibitors
08/23/2000EP0637297B1 Compounds having selectivity for retinoid x receptors
08/23/2000CN1264426A Ligand 0(cluding antibody) for display aimed-at endocrine cell reactivity
08/23/2000CN1264388A Dolastatin 15 derivatives
08/23/2000CN1264375A Crystal modification of N-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use
08/23/2000CN1264295A Lipid complexes and liposomes of highly insoluble platinum complexes
08/23/2000CN1263890A Chiral anonace-lactone compounds,and its synthesizing process and application
08/23/2000CN1055700C Therapeutic peptide derivatives
08/23/2000CN1055697C Phospholipi derivatives containing higher elements of the Vth main group
08/23/2000CN1055622C Use of root of Chinese pulsatilla for preparing preparation for treating lung cancor and gastric cancer
08/22/2000US6107520 Spisulosine compounds
08/22/2000US6107476 Nucleic acid molecule encoding a protein growth factor for inhibiting prostate cancer cell growth
08/22/2000US6107473 Kringle-related clone HTHBZ47
08/22/2000US6107472 Receptor-type tyrosine kinase-like molecules
08/22/2000US6107469 Minimum recognition unit of a pem mucin tandem repeat specific monoclonal antibody
08/22/2000US6107335 Esculentin A and esculentin B, a process for their preparation, and their use in the manufacture of medicaments
08/22/2000US6107332 Anticancer agents; antiinflammatory agents
08/22/2000US6107331 Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions
08/22/2000US6107305 Antiproferative agent, antiinflammatory agents
08/22/2000US6107297 2,4-Dithi(oxo)-pyrimidin-5-yl compounds bearing a tricyclic substituent useful as P2 purinoceptor antagonists
08/22/2000US6107291 Antiinflammatory agent
08/22/2000US6107284 Water-soluble derivatives of epipodophyllotoxin, process for their preparation, their use as medicinal products and their intended use in anti-cancer treatments
08/22/2000US6107283 Antitumor agents; diabetic therapy
08/22/2000US6107090 Treatment and diagnosis of prostate cancer with antibodies to extracellur PSMA domains
08/22/2000US6107078 Ribozymes with optimized hybridizing arms, stems, and loops, tRNA embedded ribozymes and compositions thereof
08/22/2000US6107073 Kinase capable of site-specific phosphorylation of IκBα
08/22/2000US6107071 Polynucleotide or complementary sequence which codes for a specific staphylococcus aureus amino acid sequence; for diagnosis of bacterial infections; screening of bactericides, bacteriostats, and antibiotics
08/22/2000US6107041 Detecting modulators of inhibitor of apoptosis; incubating cell that expresses inhibitor of apoptosis with modulator, monitor the expression of inhibitor of apoptosis, increase in apoptosis is indicator of the presence of a modulator
08/22/2000US6106867 Gelatinized propolis food products
08/22/2000US6106858 Loading active materials of liposomes by dissolving
08/22/2000US6106833 Bispecific antibodies, methods of production and use thereof
08/22/2000CA2187409C Stable crystalline tetrahydrofolic acid salts
08/22/2000CA2176973C Phenyl heterocycles as cyclooxygenase-2 inhibitors
08/22/2000CA2046900C Melanin-concentrating hormones and methods of treatment using same
08/17/2000WO2000047757A1 Method of producing a recombinant adeno-associated virus, suitable means for producing the same and use thereof for producing a medicament
08/17/2000WO2000047736A1 Polypeptide variants with raised heparin-binding capacity
08/17/2000WO2000047733A1 Antitumor antisense sequences directed against r1 and r2 components of ribonucleotide reductase
08/17/2000WO2000047729A1 Deglycosylated kringle 1-5 region fragments of plasminogen and methods of use
08/17/2000WO2000047725A1 Nitroreductase enzymes
08/17/2000WO2000047722A2 Chimeric virus-like particles or chimeric capsomers from bvp (bovine papilloma virus)
08/17/2000WO2000047719A2 Maturation of dendritic cells with immune response modifying compounds
08/17/2000WO2000047625A2 Humanized immunoglobulin reactive with b7 molecules and methods of treatment therewith
08/17/2000WO2000047622A2 Peptides with anti-angiogenic activity
08/17/2000WO2000047620A1 Cytokine-binding domain
08/17/2000WO2000047611A2 Polymeric immunoglobulin receptor (pigr)-binding domains and methods of use therefor
08/17/2000WO2000047607A1 A synthetic peptide disturbing intracellular signaling
08/17/2000WO2000047603A2 16-hydroxyestratrienes as selective estrogens
08/17/2000WO2000047602A1 33 human secreted proteins
08/17/2000WO2000047599A1 Novel nucleosides and oligonucleotide analogues
08/17/2000WO2000047589A1 Polyunsaturated fatty acid derivatives and their use
08/17/2000WO2000047584A2 Epothilon derivatives, method for the production and the use thereof as pharmaceuticals
08/17/2000WO2000047583A1 Cyclic substituted fused pyrrolocarbazoles and isoindolones
08/17/2000WO2000047580A2 Phenyl urea and phenyl thiourea derivatives
08/17/2000WO2000047578A1 Heteroaryl amidines, methylamidines and guanidines as protease inhibitors
08/17/2000WO2000047574A1 Heteroaryl-substituted quinolin-2-one derivatives useful as anticancer agents
08/17/2000WO2000047565A1 Pyrimidine-2,4,6-triones as inhibitors of matrix metalloproteinases
08/17/2000WO2000047564A1 Novel guanidine derivatives as inhibitors of cell adhesion
08/17/2000WO2000047562A1 Spirocyclic ketones and their use as tachykinin antagonists
08/17/2000WO2000047552A1 Tyrosine alkoxyguanidines as integrin inhibitors
08/17/2000WO2000047237A1 Encapsulated cells containing an amplified expression vector as a drug delivery device
08/17/2000WO2000047231A2 Novel antisense inhibition of rad51
08/17/2000WO2000047230A1 Anticancer agent potentiators
08/17/2000WO2000047229A2 Polynucleotide encoding multimers of antigenic peptides in order to enhance presentation of the antigenic peptide by mhc molecules
08/17/2000WO2000047228A1 Methods for treatment of tumors and metastases using a combination of anti-angiogenic and immuno therapies
08/17/2000WO2000047226A1 Tumor vaccines
08/17/2000WO2000047220A1 Controlling protein levels in eucaryotic organisms
08/17/2000WO2000047215A2 Methods for anti-tumor therapy
08/17/2000WO2000047212A1 Quinazoline derivatives as angiogenesis inhibitors
08/17/2000WO2000047163A2 Use of hyaluronic acid or fragments thereof for regulating hematopoietic differentiation
08/17/2000WO2000047149A1 Gels formed by the interaction of poly(aldehyde) with various substances
08/17/2000WO2000033870A3 New cancer treatments
08/17/2000WO2000033837A3 Myt1 kinase inhibitors
08/17/2000WO2000030590A3 Methods and compositions for diagnosis and treatment of cancer based on the transcription factor ets2
08/17/2000WO2000027819A3 Antrhranilic acid amides and the use thereof as medicaments
08/17/2000WO2000021527A3 Oxaliplatinum preparation packaging
08/17/2000WO2000015773A3 Inhibition of oncogene transcription by synthetic polyamides
08/17/2000WO2000015665A3 A method of producing a functional immunoglobulin superfamily protein
1 ... 1888 1889 1890 1891 1892 1893 1894 1895 1896 1897 1898 1899 1900 1901 1902 1903 1904 1905 1906 1907 1908 ... 2211